Organoid models in viral hepatitis,primary liver cancer,and non-alcoholic fatty liver disease:Advances and challengesOA
Organoid models in viral hepatitis,primary liver cancer,and non-alcoholic fatty liver disease:Advances and challenges
Ya-Qin Han;Yun-Yang Xu;Ze Xiang;Qiu-Fang Xu;Fei Gao;Mei-Na Yan;Jian Wu
Department of Laboratory Medicine,The People's Hospital of Dongtai City,Dongtai 224200,ChinaZhejiang University School of Medicine,Hangzhou 310009,ChinaZhejiang University School of Medicine,Hangzhou 310009,ChinaDepartment of Clinical Laboratory,The Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Gusu School,Nanjing Medical University,Suzhou 215008,ChinaDepartment of Clinical Laboratory,The Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Gusu School,Nanjing Medical University,Suzhou 215008,ChinaDepartment of Clinical Laboratory,The Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Gusu School,Nanjing Medical University,Suzhou 215008,ChinaDepartment of Clinical Laboratory,The Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou Municipal Hospital,Gusu School,Nanjing Medical University,Suzhou 215008,China
Liver diseasesOrganoidsViral hepatitisPrimary liver cancerNon-alcoholic fatty liver disease
Liver diseasesOrganoidsViral hepatitisPrimary liver cancerNon-alcoholic fatty liver disease
《国际肝胆胰疾病杂志（英文版）》 2026 (2)
134-143,10
This study was supported by grants from the National Natural Science Foundation of China(82272396)and Suzhou Medical and Health Science and Technology Innovation Project(SKY2022057 and KJXW2021043).
评论